Multiple Sclerosis Performance Test: Technical Development and Usability

ConclusionPatients with MS with varying disability levels completed the MSPT with minimal or no supervision, resulting in comprehensive, efficient, standardized, quantitative, clinically meaningful data collection as part of routine medical care, thus allowing for large-scale, real-world evidence generation.FundingBiogen.Trial RegistrationNCT02664324.

http://link.springer.com/10.1007/s12325-019-00958-x

Source: Advances in Therapy - May 2, 2019 Category: Drugs & Pharmacology Source Type: research